Mips schedules Q3 results presentation conference call
Bitget2026/10/12 12:04- Mips schedules its Q3 2026 interim report release for Oct. 21, 2026 at 7:30 a.m. CET.
- Management will discuss the results on a conference call at 11:00 a.m. CET, with access via webcast or telephone registration.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
London Gold and Silver Vault Data for September 2026
Bristol-Myers Squibb (BMY.US) rises in pre-market trading! Two experimental drugs report positive results in Phase 3 clinical trials, diversifying and accelerating the pipeline
Bristol Myers Squibb's two experimental drugs, used to treat a rare endocrine cancer and a deadly lung disease, have achieved success in Phase III clinical trials, injecting momentum into the pharmaceutical company’s new product pipeline.
BUZZ-Enovix shares rise on preliminary revenue growth in the third quarter